Cite
HARVARD Citation
Dhakal, P. et al. (2020). Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?. Leukemia & lymphoma. 61 (1), pp. 7-17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dhakal, P. et al. (2020). Immunotherapeutic options for management of relapsed or refractory B-cell acute lymphoblastic leukemia: how to select newly approved agents?. Leukemia & lymphoma. 61 (1), pp. 7-17. [Online].